Delivery Order SPE2DB22D2211-SPE2DB24FNVB8
Award Date
6/26/24
Potential Completion Date
6/27/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,468.11, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 24, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a...
This federal contract award is for the delivery of VYVANSE 60 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on September 17, 2024, with a ceiling value of $1,724.00 and a completion date of September 18, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a...
This federal contract award is for the delivery of VYVANSE 20 MG CAPSULE 100S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and has a ceiling value of $2,809.24. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of June 3, 2024. The contract was not designated with any set-aside requirements, indicating...
This federal contract award is for the delivery of VYVANSE 50 MG CAPSULE 100S to the Defense Logistics Agency (DLA), with a ceiling value of $1,617.28. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and is a Delivery Order under an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award is for the delivery of VYVANSE 30 MG CAPSULE 100S pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The contract has a ceiling value of $4,668.22 and is structured as a Delivery Order with a Firm Fixed Price pricing type. It does not have a...
This federal contract award is for the delivery of VYVANSE 40 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,649.20, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price with a completion date of December 17, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at...
This federal contract award is for the delivery of VYVANSE 60 MG CAPSULE 100S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, on a firm-fixed-price basis with a ceiling value of $3,963.16. The contract has an ultimate completion date of April 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of 4565242911 - VYVANSE 40 MG CAPSULE 100S to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a firm fixed price of $1,139.68. The contract is classified as a Delivery Order and does not have a set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division holds a large Indefinite Delivery...
This federal contract award is for the delivery of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product, to the Department of Defense (DoD) and its Medical Supply Chain. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on May 15, 2024 with a ceiling value of $7,141.46. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 16, 2024. Amerisourcebergen Drug Corp's Corporate Office...
This federal contract award is for the delivery of VYVANSE 70 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The $1,927.45 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on January 24, 2025, with an ultimate completion date of January 27, 2025. The contract is not designated as a set-aside procurement. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that...